Breast Cancer Trial, Recruiting NCT06214598 Sponsor: University of Belgrade Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06214598
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 45 and 70 years old
  • You are a woman who has gone through menopause
  • You have been diagnosed with breast cancer (confirmed by a tissue test), at an early to moderate stage (Stage I to IIIa)
  • Your breast cancer is hormone receptor positive (ER+) and HER2 negative
  • You have been taking hormone therapy called aromatase inhibitors for between 6 and 30 months
  • Your body weight falls within a moderate range — specifically, your BMI is between 20 and 34.9 (confirm with trial site if unsure of your BMI)
  • You are able to understand what the study involves and are willing to sign a consent form

Who may not be able to join:

  • Your cancer has spread to other parts of the body or has become locally advanced
  • Your breast cancer is HER2-positive
  • You have another type of cancer or a serious long-term illness
  • You currently have an active infection
  • You have previously had a stroke or heart attack
  • You have rheumatoid arthritis or another autoimmune disease
  • You have a significant problem with your nervous system (confirm with trial site)
  • You have dementia
  • You are allergic to fish, fish oil, nuts, or any ingredients in the dietary supplement used in this study
  • You are allergic to evening primrose oil or other oils containing gamma-linolenic acid (such as borage or black currant oil)
  • You are currently taking cholesterol-lowering medications such as statins or Normolip
  • You are currently taking warfarin or any other blood-thinning medication
  • You have taken steroid (corticosteroid) medication within the last month
  • You have taken supplements such as fish oil, evening primrose oil, flaxseed oil, omega 3-6-9 fatty acids, or multivitamins containing omega-3 in the 3 months before the study starts

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Belgrade
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
31 March 2025

Where this trial is recruiting

🇷🇸 Serbia

Primary endpoints

Nutritional status; Nutritional status; Nutritional status; Changes in Quality of life; Changes in Quality of life; Changes in Quality of life; Clinical outcome; Clinical outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov